Suppr超能文献

2020 年 1 月至 2 月期间,中国武汉一家医院对 4880 例病例进行的 SARS-CoV-2 感染的 RT-PCR 检测阳性率。

Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020.

机构信息

Dept. of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China.

Dept. State Key Laboratory of Virology (Wuhan University), College of Life Sciences of Wuhan University, Wuhan 430072, Hubei, China; Dept. Wuhan Institute of Biotechnology, Wuhan 430075, Hubei, China.

出版信息

Clin Chim Acta. 2020 Jun;505:172-175. doi: 10.1016/j.cca.2020.03.009. Epub 2020 Mar 7.

Abstract

BACKGROUND

There's an outbreak of a novel coronavirus (SARS-CoV-2) infection since December 2019, first in China, and currently with more than 80 thousand confirmed infection globally in 29 countries till March 2, 2020. Identification, isolation and caring for patients early are essential to limit human-to-human transmission including reducing secondary infections among close contacts and health care workers, preventing transmission amplification events. The RT-PCR detection of viral nucleic acid test (NAT) was one of the most quickly established laboratory diagnosis method in a novel viral pandemic, just as in this COVID-19 outbreak.

METHODS

4880 cases that had respiratory infection symptoms or close contact with COVID-19 patients in hospital in Wuhan, China, were tested for SARS-CoV-2 infection by use of quantitative RT-PCR (qRT-PCR) on samples from the respiratory tract. Positive rates were calculated in groups divided by genders or ages.

RESULTS

The positive rate was about 38% for the total 4880 specimens. Male and older population had a significant higher positive rates. However, 57% was positive among the specimens from the Fever Clinics. Binary logistic regression analysis showed that age, not gender, was the risk factor for SARS-CoV-2 infection in fever clinics.

CONCLUSIONS

Therefore, we concluded that viral NAT played an important role in identifying SARS-CoV-2 infection.

摘要

背景

自 2019 年 12 月以来,一种新型冠状病毒(SARS-CoV-2)感染爆发,首先在中国,截至 2020 年 3 月 2 日,全球 29 个国家已有超过 8 万例确诊感染。早期识别、隔离和照顾患者对于限制人与人之间的传播至关重要,包括减少密切接触者和医护人员中的二次感染,防止传播放大事件。病毒核酸检测(NAT)的 RT-PCR 检测是新型病毒大流行中最快建立的实验室诊断方法之一,就像在 COVID-19 爆发中一样。

方法

在中国武汉的医院中,对 4880 例有呼吸道感染症状或与 COVID-19 患者有密切接触的患者的呼吸道样本进行了 SARS-CoV-2 感染的定量 RT-PCR(qRT-PCR)检测。按性别或年龄分组计算阳性率。

结果

4880 份标本的阳性率约为 38%。男性和老年人群的阳性率显著更高。然而,发热门诊标本的阳性率为 57%。二项逻辑回归分析显示,年龄而不是性别是发热门诊 SARS-CoV-2 感染的危险因素。

结论

因此,我们得出结论,病毒 NAT 在识别 SARS-CoV-2 感染方面发挥了重要作用。

相似文献

引用本文的文献

本文引用的文献

8
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验